Quest Diagnostics Incorporated Stock Revenue
| DGX Stock | USD 173.48 3.32 1.95% |
Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 9.9 B | 7 B |
Quest | Revenue |
Quest Diagnostics Incorporated Company Revenue Analysis
Quest Diagnostics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Quest Diagnostics Revenue | 9.87 B |
Most of Quest Diagnostics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Quest
Projected quarterly revenue analysis of Quest Diagnostics provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Quest Diagnostics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Quest Diagnostics' stock price.
Quest Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Quest Diagnostics is extremely important. It helps to project a fair market value of Quest Stock properly, considering its historical fundamentals such as Revenue. Since Quest Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quest Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quest Diagnostics' interrelated accounts and indicators.
| 0.48 | 0.5 | 0.22 | 0.64 | 0.24 | ||
| 0.48 | 0.99 | -0.03 | 0.81 | 0.83 | ||
| 0.5 | 0.99 | 0.07 | 0.84 | 0.78 | ||
| 0.22 | -0.03 | 0.07 | 0.37 | -0.17 | ||
| 0.64 | 0.81 | 0.84 | 0.37 | 0.55 | ||
| 0.24 | 0.83 | 0.78 | -0.17 | 0.55 |
Click cells to compare fundamentals
Quest Revenue Historical Pattern
Today, most investors in Quest Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Quest Diagnostics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Quest Diagnostics revenue as a starting point in their analysis.
Quest Diagnostics Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Quest Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Quest Diagnostics Incorporated reported 9.87 B of revenue. This is 29.44% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 4.63% lower than that of the firm.
Quest Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.Quest Diagnostics is currently under evaluation in revenue category among its peers.
Quest Diagnostics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.Environmental | Governance | Social |
Quest Diagnostics Institutional Holders
Institutional Holdings refers to the ownership stake in Quest Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Quest Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Quest Diagnostics' value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.6 M | American Century Companies Inc | 2024-12-31 | 1.5 M | Wells Fargo & Co | 2024-12-31 | 1.4 M | Amvescap Plc. | 2024-12-31 | 1.4 M | Fiduciary Management, Inc. Of Milwaukee | 2024-12-31 | 1.3 M | Norges Bank | 2024-12-31 | 1.3 M | Northern Trust Corp | 2024-12-31 | 1.2 M | Fmr Inc | 2024-12-31 | 1.1 M | Alliancebernstein L.p. | 2024-12-31 | 1.1 M | Vanguard Group Inc | 2024-12-31 | 14 M | Blackrock Inc | 2024-12-31 | 10.1 M |
Quest Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0584 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 25.42 B | ||||
| Shares Outstanding | 110.98 M | ||||
| Shares Owned By Insiders | 0.44 % | ||||
| Shares Owned By Institutions | 93.73 % | ||||
| Number Of Shares Shorted | 2.57 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 2.79 X | ||||
| Price To Sales | 1.91 X | ||||
| Revenue | 9.87 B | ||||
| Gross Profit | 3.27 B | ||||
| EBITDA | 1.91 B | ||||
| Net Income | 921 M | ||||
| Cash And Equivalents | 315 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 6.92 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 61.06 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Short Ratio | 2.12 X | ||||
| Earnings Per Share | 7.69 X | ||||
| Price To Earnings To Growth | 1.39 X | ||||
| Target Price | 176.97 | ||||
| Number Of Employees | 45 K | ||||
| Beta | 0.92 | ||||
| Market Capitalization | 18.88 B | ||||
| Total Asset | 16.15 B | ||||
| Retained Earnings | 9.36 B | ||||
| Working Capital | 223 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.89 % | ||||
| Net Asset | 16.15 B | ||||
| Last Dividend Paid | 3.0 |
About Quest Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.